Supplying Scientific & Clinically Substantiated Products
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, the company has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. Its present operations have grown to employ 1,000 people worldwide in 10 manufacturing, R&D and/or distribution facilities. Additionally, botanical cultivation efforts undertaken by the organization now total nearly 40,000 acres to ensure sustainable supplies on its key products. All products intended for human consumption are certified kosher and halal.
Sabinsa’s mission is to be a responsible biotechnology-based research, manufacturing and marketing company supplying the finest raw materials to provide innovative solutions to the dietary supplement, cosmetic, specialty chemical and pharmaceutical industries. The company’s specialized services include custom product development, technical support and testing lab facilities, assistance in clinical evaluation and protocol implementation. At its Utah plant, Sabinsa has contract manufacturing services to help customers develop tablets, bi-layer tablets, capsules as well as intermediary services such as milling, blending, roll compacting and granulation. The company has established marketing offices in the U.S., Australia, China, Europe, Japan, South Korea and South Africa. Sabinsa also has agents that represent its product line throughout South America and Far East Asia. adiponectin levels.
Science or Technical Merit
Emphasis on developing and bringing to market products with scientific and clinical substantiation is Sabinsa’s core business philosophy and is in large part responsible for fueling the company’s ongoing commercial success. The company has obtained several IND-approved clinical protocols for its products from the FDA. With more than 100 scientists working full-time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent beneficial nutrients for the world market.
Presently, Sabinsa owns more than 80 U.S. and international patents, and has 75 pending patent applications worldwide. The company is also a three-time recipient of the prestigious Thomas Alva Edison Patent Award, given annually by the New Jersey R&D Council in recognition of the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey.
The company also has many recognized trademarked ingredients such as Bacopin®, BioPerine®, Boswellin®, Citrin®, Cosmoperine®, Curcumin C3 Complex®, Curcumin C3 Reduct®, DigeZyme®, Fabenol®, FenuFibers®, Fenusterols®, ForsLean®, Gugulipid®, Gymnema Sylvestre GS4®, LactoSpore®, LactoWise®, Momordicin®, Picroliv®, Resvenox®, Saberry®, Salaretin®, Selenium SeLECT®, Silbinol® and Venocin®.
Committed and dedicated to the principles of innovation, tradition and research, Sabinsa supplies high-quality, innovative, standardized herbal extracts, phytonutrients, probiotics, enzymes, spice extracts, minerals, specialty chemicals and fine chemicals for applications in dietary supplements, functional foods, pharmaceuticals and cosmetics. Every product is backed by application-oriented scientific research. Sabinsa Corporation has developed novel approaches to retaining the biological activity of these ingredients while simultaneously addressing formulation challenges and product safety criteria.
• Muhammed Majeed, PhD, Founder & Owner
• N. Kalyanam, PhD, President of R&D
• Reza Kamarei, PhD, Vice President of Science & Technology